Stocks

Regions Financial Corporation (NYSE:RF) Q1 2024 Earnings Call Transcript April 19, 2024 Regions Financial Corporation isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome to the …

Looking at Corbion N.V.'s (AMS:CRBN ) insider transactions over the last year, we can see that insiders were net buyers. That is, there were more number of shares purchased by insiders than there were sold. While insider transactions are not the most important thing …

Expanded partnership will leverage Microsoft Copilot and Cognizant's advisory and digital transformation services to help employees and enterprise customers operationalize generative AI and realize strategic business transformation. TEANECK, N.J., April 22, 2024 /PRNewswire/ -- Cognizant (Nasdaq: CTSH) and Microsoft Corp. announced an expanded partnership …

Global 5G leader to join Environment and Climate Change Canada's (ECCC) Net-Zero Challenge program aimed at reducing GHG emissions in cooperation with private sector companies. TORONTO, April 22, 2024 /PRNewswire/ --Ericsson Canada (NASDAQ: ERIC) is proud to celebrate Earth Day today by announcing that …

A. O. Smith Corporation AOS is likely to witness top bottom-line growth when it reports first-quarter 2024 results on Apr 25, before the opening bell. The Zacks Consensus Estimate for revenues is pegged at $995 million, which suggests growth of 3% from the year-ago …

Wall Street’s impressive bull run for the last 15 months has been facing severe hurdles in April. Historically, this month is known as favorable to equity investors. However, this year it is turning out to be different. Month to date, the three major stock …

EMBLAVEO® is the first β-lactam/β-lactamase inhibitor antibiotic combination approved in the European Union for treating serious infections in adult patients caused by multidrug-resistant Gram-negative bacteria, including metallo-β-lactamase-producing bacteria EMBLAVEO® was reviewed under European Medicines Agency accelerated assessment procedure, used when a pharmaceutical product is …